Evidence map›Paper›PMID 37014986›Full record

Trial reportAnesthesiology2023

Morphine and Hydromorphone Effects, Side Effects, and Variability: A Crossover Study in Human Volunteers.

Konrad Meissner, Albert Dahan, Erik Olofsen, Christine Göpfert, Jane Blood, Johannes Wieditz, Evan D Kharasch

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Anesthesiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Morphine versus hydromorphone pharmacokineticAnnals of translational medicine · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Impact of Replacing Fentanyl With Hydromorphone as the First-Line Postoperative Opioid Among Patients Undergoing Outpatient Cancer Surgery.Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses · 2024
    Article
  15. Article
  16. Use of CaudalAnimals : an open access journal from MDPI · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Konrad MeissnerDepartment of Anesthesiology, University Medical Center Göttingen, Göttingen, Germany; Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Anesthesiology, Washington University in St. Louis, St. Louis, Missouri.ORCID 0000-0001-9960-5453
Albert DahanDepartment of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands.
Erik OlofsenDepartment of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands.
Christine GöpfertChronic Pain Therapy, Kliniken Ostalb, Ellwangen, Germany; Department of Anesthesiology, Washington University in St. Louis, St. Louis, Missouri.
Jane BloodDepartment of Anesthesiology, Washington University in St. Louis, St. Louis, Missouri.
Johannes WieditzAnesthesiology Clinic, and Department of Medical Statistics, University of Medicine Göttingen, Göttingen, Germany.
Evan D KharaschDepartment of Anesthesiology, Duke University, Durham, North Carolina.
Leiden University Medical Center · NLWashington University in St. Louis · USDuke University · USUniversitätsmedizin Göttingen · DE

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
METHADONE AND HIV DRUG INTERACTIONSR01DA014211 · NIDA · WASHINGTON UNIVERSITY · PI KHARASCH, EVAN D. · 2001 to 2012
$4.8M
OPTIMIZING OUTPATIENT ANESTHESIA: IMPROVING ANALGESIA AND REDUCING OPIOID MISADVENTURER01DA042985 · NIDA · WASHINGTON UNIVERSITY · PI KHARASCH, EVAN D. · 2017 to 2021
$2.2M
OPIOIDS IN CANCER PAIN &DRUG ABUSE--OPTIMIZING THERAPYK24DA000417 · NIDA · WASHINGTON UNIVERSITY · PI KHARASCH, EVAN D. · 1999 to 2010
$1.4M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NIDA NIH HHS K24 DA000417NIDA NIH HHS R01 DA014211NIDA NIH HHS R01 DA042985
6 · The paper itself

Abstract

backgroundBalancing between opioid analgesia and respiratory depression continues to challenge clinicians in perioperative, emergency department, and other acute care settings. Morphine and hydromorphone are postoperative analgesic standards. Nevertheless, their comparative effects and side effects, timing, and respective variabilities remain poorly understood. This study tested the hypothesis that IV morphine and hydromorphone differ in onset, magnitude, duration, and variability of analgesic and ventilatory effects.

methodsThe authors conducted a randomized crossover study in healthy volunteers. Forty-two subjects received a 2-h IV infusion of hydromorphone (0.05 mg/kg) or morphine (0.2 mg/kg) 1 to 2 weeks apart. The authors measured arterial opioid concentrations, analgesia in response to heat pain (maximally tolerated temperature, and verbal analog pain scores at discrete preset temperatures to determine half-maximum temperature effect), dark-adapted pupil diameter and miosis, end-expired carbon dioxide, and respiratory rate for 12 h after dosing.

resultsFor morphine and hydromorphone, respectively, maximum miosis was less (3.9 [3.4 to 4.2] vs. 4.6 mm [4.0 to 5.0], P < 0.001; median and 25 to 75% quantiles) and occurred later (3.1 ± 0.9 vs. 2.3 ± 0.7 h after infusion start, P < 0.001; mean ± SD); maximum tolerated temperature was less (49 ± 2 vs. 50 ± 2°C, P < 0.001); verbal pain scores at end-infusion at the most informative stimulus (48.2°C) were 82 ± 4 and 59 ± 3 (P < 0.001); maximum end-expired CO2 was 47 (45 to 50) and 48 mmHg (46 to 51; P = 0.007) and occurred later (5.5 ± 2.8 vs. 3.0 ± 1.5 h after infusion start, P < 0.001); and respiratory nadir was 9 ± 1 and 11 ± 2 breaths/min (P < 0.001), and occurred at similar times. The area under the temperature tolerance-time curve was less for morphine (1.8 [0.0 to 4.4]) than hydromorphone (5.4°C-h [1.6 to 12.1] P < 0.001). Interindividual variability in clinical effects did not differ between opioids.

conclusionsFor morphine compared to hydromorphone, analgesia and analgesia relative to respiratory depression were less, onset of miosis and respiratory depression was later, and duration of respiratory depression was longer. For each opioid, timing of the various clinical effects was not coincident. Results may enable more rational opioid selection, and suggest hydromorphone may have a better clinical profile. EDITOR’S PERSPECTIVE:

Indexed as

Drug-Related Side Effects and Adverse ReactionsRespiratory InsufficiencyAnalgesics, OpioidCross-Over StudiesDouble-Blind MethodHealthy VolunteersHumansHydromorphoneMiosisMorphinePainPostoperative PainAnalgesics, OpioidHydromorphoneMorphine

Identifiers

PMID37014986
PMCPMC10517626
OpenAlexW4362593614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.